华森制药：2025年上半年净利润同比增长14.27%

Group 1 - The core viewpoint of the article highlights that Huason Pharmaceutical reported a revenue of 442 million yuan for the first half of 2025, reflecting a year-on-year growth of 5.76% [1] - The net profit for the same period was 53.95 million yuan, showing a year-on-year increase of 14.27% [1] - The company plans to distribute a cash dividend of 0.35 yuan (including tax) for every 10 shares to all shareholders [1]